An Update on Local Steroids for Uveitis - Takeaways - MDSpire

An Update on Local Steroids for Uveitis

  • By

  • Sruthi Arepalli, MD

  • July 14, 2025

  • 4 min

Share

  • 1

    Local steroids are a first-line treatment for uveitis, providing intraocular inflammation control without systemic immunosuppression.

  • 2

    Retisert, a fluocinolone acetonide implant, will be discontinued in April 2026 due to manufacturing difficulties, prompting patients to seek alternatives.

  • 3

    Triesence, a preservative-free triamcinolone acetonide injectable, faced a drug shortage but is set to relaunch in late 2024 with a significant price increase.

  • 4

    Yutiq, an injectable intravitreal insert, releases steroids for up to 36 months and is indicated for chronic noninfectious uveitis.

  • 5

    ANI Pharmaceuticals acquired Alimera Sciences, expanding Iluvien's label to include chronic noninfectious posterior uveitis, aligning it with European approvals.

Original Source(s)

Related Content